Blood Cancer United Acquires Investigational Drug Supply to Preserve Access for Children with Rare, Fatal Leukemia

First-of-its-kind nonprofit intervention enables continued compassionate use of a promising treatment for children facing a 15% to 30% survival rate WASHINGTON, June 11, 2026 /PRNewswire/ -- In an unprecedented intervention, Blood Cancer United announced that it has acquired the remaining...